COMPASS THERAPEUTICS, INC. Proceeds from Sale of Available-for-sale Securities, Equity
COMPASS THERAPEUTICS, INC. (CMPX) reported Proceeds from Sale of Available-for-sale Securities, Equity of $329.00 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity · last filed 2022-05-09
- COMPASS THERAPEUTICS, INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2022-03-31 was $329.00M, a 149.24% increase year-over-year.
- COMPASS THERAPEUTICS, INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2021-09-30 was $0.00.
- COMPASS THERAPEUTICS, INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2021-06-30 was $0.00.
- COMPASS THERAPEUTICS, INC. proceeds from sale of available-for-sale securities, equity for the quarter ending 2021-03-31 was $132.00M.
| Period end | Proceeds from Sale of Available-for-sale Securities, Equity 3 month | Proceeds from Sale of Available-for-sale Securities, Equity 6 month | Proceeds from Sale of Available-for-sale Securities, Equity 9 month |
|---|---|---|---|
| 2022-03-31 | $329.00M 10-Q · filed 2022-05-09 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $132.00M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $132.00M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $132.00M 10-Q · filed 2021-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |